T2 Biosystems, Inc.
Viés de alta

T2 Biosystems Long Term 2023 Target $22

T2 Biosystems Revenue for Q3 2021 was exceptionally good.
Expecting $5.48 by end of 2021/Q1-2022, followed by $22 by 2023 long term.
#t2biosystems
biosystemsChart PatternsTechnical Indicatorst2t2biot2biosystemsTrend Analysis

Aviso legal